A
Power Law company profile
Alector
Biotech & Life Sciences · San Francisco, United States · Founded 2013 · IPO 2019 Unicorn
Valuation
$36M
Market cap · Apr/2026
Revenue
$21M
Latest reported FY
Global footprint
Where Alector has talent and traffic
AI talent share
1.9%
of workforce is AI talent
(3 of 154 staff)
(3 of 154 staff)
Core AI10.65%
Other AI21.3%
Non-AI workforce15198.05%
Web traffic by country
12K
monthly visits
across markets
across markets
🇺🇸 United States52.5%
🏳️ Latvia28.3%
🇮🇳 India17.5%
🇩🇪 Germany2.5%
🇨🇦 Canada0%
Patent intelligence
$93M patent portfolio · 67 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$93M
256.3% of market cap · 8.4× smaller than top peer BioNTech ($780M)
67 active patent families
Where Alector innovates
Molecular biologyAntiendomysial antibodiesAntibody fragmentsMonoclonalAnti antibody
Tracks the peer median across all five Patsnap quality dimensions.
Quality vs same-sector peers
Alector on the five Patsnap quality dimensions
Alector in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where Alector concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across Alector and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee Alector on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.